Variation in therapeutic strategies for the management of severe COVID-19 in India- A nationwide cross-sectional survey

6/25 Review

Jagiasi et al., The International Journal of Clinical Practice, doi:10.1111/ijcp.14574 (Review) (Peer Reviewed)
Variation in therapeutic strategies for the management of severe COVID-19 in India- A nationwide cross-sectional survey

Source PDF Share Tweet

Survey of medication use for severe COVID-19 in India, showing 33% adoption of ivermectin as of January 2021.

Jagiasi et al., 6/25/2021, peer-reviewed, 19 authors.

All 113 studies Meta Analysis

Please send us corrections, updates, or comments. Vaccines and treatments are both extremely valuable and complementary. All practical, effective, and safe means should be used. Elimination of COVID-19 is a race against viral evolution. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. Denying the efficacy of any method increases the risk of COVID-19 becoming endemic; and increases mortality, morbidity, and collateral damage. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. Treatment protocols for physicians are available from the FLCCC.

Submit